Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liblau, R.
Right arrow Articles by McDevitt, H. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liblau, R.
Right arrow Articles by McDevitt, H. O.
NEUROLOGY 1993;43:1192
© 1993 American Academy of Neurology

Antigen processing gene polymorphisms in HLA-DR2 multiple sclerosis

R. Liblau, MD, P. M. van Endert, MD, M. Sandberg-Wollheim, MD, PhD, S. D. Patel, PhD, M. T. Lopez, PhD, S. Land, MS, L. Fugger, MD, PhD and H. O. McDevitt, MD

Department of Microbiology and Immunology (Drs. Liblau, van Endert, Patel, Lopez, Fugger, and McDevitt), Stanford University School of Medicine, Stanford, CA; the Department of Neurology (Dr. Sandberg-Wollheim), University Hospital, Lund, Sweden; and the Department of Statistics (S. Land), Stanford University, Stanford, CA.

The association between multiple sclerosis (MS) and alleles of the HLA class II genes indicates that at least one MS susceptibility gene is linked to the HLA class II region. However, the actual locus responsible has not been precisely identified. The recent cloning of new genes involved in antigen processing that map within the HLA class II region led us to investigate–using the restriction fragment length polymorphism (RFLP) technique and sequence-specific oligonucleotide analysis–whether these genes might play a role in conferring susceptibility to MS. We studied large multifunctional protease (LMP) 2 and 7 and transporter associated with antigen processing (TAP) 1 and 2 gene polymorphisms in 60 HLA-DR2 MS patients and 60 HLA-DR2 healthy subjects and found no specific or preferential RFLP patterns or coding sequence variants in the patient group. Our data do not support a role for these genes in MS susceptibility.

Address correspondence and reprint requests to Dr. R. Liblau, Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305.

Received July 7, 1992. Accepted for publication in final form October 28, 1992.

R. Liblau was supported in part by the International Brain Research Organisation.




This article has been cited by other articles:


Home page
JAMAHome page
J. R. Oksenberg, A. B. Begovich, H. A. Erlich, and L. Steinman
Genetic Factors in Multiple Sclerosis
JAMA, November 17, 1993; 270(19): 2362 - 2369.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by AAN Enterprises, Inc.